A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
Memorial Sloan Kettering Cancer Center
Study ID
NCT06312124
Status
Recruiting
Apply to this trial

Conditions

  • Surgery

Eligibility Criteria

Sex
FEMALE
Age
45 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Educational Module — BEHAVIORAL
    Part 1 consists of an education module with premodule and postmodule assessment questionnaires.
  • Salpingectomy — PROCEDURE
    Part 2 consists of incorporating opportunistic salpingectomy /OS into non-gynecologic surgery

Study Details

The purpose of this study is to find out how many participants are interested in a surgical preventive procedure after watching an educational video. Before and after watching the video, participants will complete questionnaires in the clinic.

Key Dates

Start date
Mar 8, 2024
Status verified
Jan 2026
Primary completion
Mar 8, 2028
Completion
Mar 8, 2028

Study Design

Enrollment
266 participants (estimated)
Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
PREVENTION

Arms

  • Experimental: Participants scheduled for non-gynecologic abdominopelvic surgery
    Participants will be aged ≥45 years, have at least 1 fallopian tube, will not desire or plan to have children in the future, and will be scheduled to undergo non-gynecologic abdominopelvic surgery.

Primary Outcome Measure

Rate of Opportunistic Salpingectomy/OS after completion of educational module [ Time Frame: up to 2 years ]

Central Contacts

Locations (10)

FacilityCityStateZIPSite coordinators
Johns Hopkins University (Data Collection Only)BaltimoreMaryland21287
Rebecca Stone, MD
410-955-8240
Dana Farber Cancer Institute (Data Collection Only)BostonMassachusetts02115
Michelle Davis, MD
617-732-8840
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)Basking RidgeNew Jersey07920
Kara Long Roche, MD
646-608-3787
Memorial Sloan Kettering Monmouth (Limited protocol activities)MiddletownNew Jersey07748
Kara Long Roche, MD
646-608-3787
Memorial Sloan Kettering Bergen (Limited Protocol Activities)MontvaleNew Jersey07645
Kara Long Roche, MD
646-608-3787
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities)CommackNew York11725
Kara Long Roche, MD
646-608-3787
Memorial Sloan Kettering Westchester (Limited Protocol Activities)HarrisonNew York10604
Kara Long Roche, MD
646-608-3787
Memorial Sloan Kettering Cancer Center (All Protocol Activities)New YorkNew York10065
Kara Long Roche, MD
646-608-3787
Memorial Sloan Kettering Nassau (Limited Protocol Activities)UniondaleNew York11553
Kara Long Roche, MD
646-608-3787
MD Anderson Cancer Center (Data Collection Only)HoustonTexas77030
Larissa Meyer, MD
713-792-6161

Find similar trials in Baltimore, MD

By research site
Johns Hopkins University (Data Collection Only)· Baltimore, MDDana Farber Cancer Institute (Data Collection Only)· Boston, MAMemorial Sloan Kettering Basking Ridge (Limited Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (Limited protocol activities)· Middletown, NJMemorial Sloan Kettering Bergen (Limited Protocol Activities)· Montvale, NJMemorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities)· Commack, NY

Related Studies